Literature DB >> 21991122

Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)*.

B S Atiyeh1, S W A Gunn, S A Dibo.   

Abstract

Severe burn patients are some of the most challenging critically ill patients, with an extreme state of physiological stress and an overwhelming systemic metabolic response. Increased energy expenditure to cope with this insult necessitates mobilization of large amounts of substrate from fat stores and active muscle for repair and fuel, leading to catabolism. The hypermetabolic response can last for as long as nine months to one year after injury and is associated with impaired wound healing, increased infection risks, erosion of lean body mass, hampered rehabilitation, and delayed reintegration of burn survivors into society. Reversal of the hypermetabolic response by manipulating the patient's physiological and biochemical environment through the administration of specific nutrients, growth factors, or other agents, often in pharmacological doses, is emerging as an essential component of the state of the art in severe burn management. Early enteral nutritional support, control of hyperglycaemia, blockade of catecholamine response, and use of anabolic steroids have all been proposed to attenuate hypermetabolism or to blunt catabolism associated with severe burn injury. The present study is a literature review of the proposed nutritional and metabolic therapeutic measures in order to determine evidence-based best practice. Unfortunately, the present state of our knowledge does not allow the formulation of clear-cut guidelines. Only general trends can be outlined which will certainly have some practical applications but above all will dictate future research in the field.

Entities:  

Keywords:  METABOLIC; NUTRITIONAL; PATIENTS; PHARMACOLOGICAL MODULATION; Part II

Year:  2008        PMID: 21991122      PMCID: PMC3188173     

Source DB:  PubMed          Journal:  Ann Burns Fire Disasters        ISSN: 1592-9558


  44 in total

1.  Role of beta-adrenergic receptor subtypes in lipolysis.

Authors:  S N Louis; G P Jackman; T L Nero; D Iakovidis; W J Louis
Journal:  Cardiovasc Drugs Ther       Date:  2000-12       Impact factor: 3.727

2.  Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy.

Authors:  D W Hart; D N Herndon; G Klein; S B Lee; M Celis; S Mohan; D L Chinkes; S E Wolf
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

3.  Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment.

Authors:  D N Herndon; P I Ramzy; M A DebRoy; M Zheng; A A Ferrando; D L Chinkes; J P Barret; R R Wolfe; S E Wolf
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

4.  Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults.

Authors:  M A Debroy; S E Wolf; X J Zhang; D L Chinkes; A A Ferrando; R R Wolfe; D N Herndon
Journal:  J Trauma       Date:  1999-11

5.  Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children.

Authors:  M G Jeschke; R E Barrow; D N Herndon
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

6.  Nutritional and pharmacological modulation of the metabolic response of severely burned patients: review of the literature (part 1).

Authors:  B S Atiyeh; S W A Gunn; S A Dibo
Journal:  Ann Burns Fire Disasters       Date:  2008-06-30

7.  Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet.

Authors:  Beatrice Morio; Oivind Irtun; David N Herndon; Robert R Wolfe
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

8.  Insulin-like growth factor 1 (IGF-1) in burn patients.

Authors:  S Møller; M Jensen; P Svensson; N E Skakkebaek
Journal:  Burns       Date:  1991-08       Impact factor: 2.744

9.  Beta-blocker use is associated with improved outcomes in adult burn patients.

Authors:  Saman Arbabi; Karla S Ahrns; Wendy L Wahl; Mark R Hemmila; Stewart C Wang; Mary-Margaret Brandt; Paul A Taheri
Journal:  J Trauma       Date:  2004-02

10.  Insulin treatment improves the systemic inflammatory reaction to severe trauma.

Authors:  Marc G Jeschke; Dagmar Klein; David N Herndon
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

View more
  4 in total

1.  Management of burns in the elderly.

Authors:  G S Abu-Sittah; F M Chahine; H Janom
Journal:  Ann Burns Fire Disasters       Date:  2016-12-31

Review 2.  Physical rehabilitation of pediatric burns.

Authors:  B Atiyeh; H H Janom
Journal:  Ann Burns Fire Disasters       Date:  2014-03-31

3.  Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part III)*.

Authors:  B S Atiyeh; S W A Gunn; S A Dibo
Journal:  Ann Burns Fire Disasters       Date:  2008-12-31

4.  A randomized controlled trial to compare the effects of liquid versus powdered recombinant human growth hormone in treating patients with severe burns.

Authors:  Guoxian Chen; Huawei Shao; Xuanliang Pan
Journal:  Biomed Rep       Date:  2016-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.